Literature DB >> 33815919

Proteinuria versus albuminuria in 24-hour urine collection: prevalence and clinical outcome in non-hypoxemic adult patients with congenital heart disease.

Efrén Martínez-Quintana1,2, Alejandro Barreto-Martín2, Hiurma Estupiñán-León2, Ana Beatriz Rojas-Brito2, Liuva Déniz-Déniz2, Fayna Rodríguez-González3.   

Abstract

Congenital heart disease (CHD) patients, especially cyanotic ones, usually have renal function impairment. However, little information exists in non-cyanotic CHD patients. The objective of this study is to determine renal failure in non-hypoxemic CHD patients by measuring the amount of protein and albumin released in urine over a 24-hour period and determining the glomerular filtration rate (GFR). Prospective study of consecutive outpatient non-hypoxemic CHD patients followed up in a single tertiary referral hospital. Demographic, clinical, blood test and 24-hour urine collection were recorded. 264 CHD patients, 22 (18-343) years old and 160 (61%) males, were followed up during 9.2 (5.9-11.1) years. 137 (52%), 96 (36%) and 31 (18%) CHD patients had mild, moderate, and great anatomical CHD defects. 44 (17%) and 32 (12%) CHD patients showed proteinuria (≥ 150 mg/24 hours) and albuminuria (> 30 mg/24 hours) respectively. 35 out of 44 (79%) CHD patients with proteinuria (≥ 150 mg/24 hours) showed normal to mild albuminuria levels (< 30 mg/24 hours). Variables associated with proteinuria were male sex, body mass index, auricular fibrillation/flutter, arterial hypertension, diabetes mellitus and being under angiotensin-converting enzyme (ACE) inhibitor and an angiotensin receptor blocker (ARB), loop diuretics or anti-aldosterone treatment. Major adverse cardiovascular events (MACE), defined as cardiovascular and non-cardiovascular deaths, stroke, myocardial infarction and heart failure requiring hospitalization, occurred in 16 (6%) patients during the follow up time. Multivariate Cox regression analysis showed that older patients, patients with a great CHD complexity and patients with proteinuria [6.99 (1.90-24.74), P=0.003] had a significant higher risk of MACE. Proteinuria is frequent among non-hypoxemic CHD patients and occurs mostly in those with a GFR above 60 ml/min/1.73 m2 and normal to mild albuminuria levels. Having proteinuria, but not albuminuria, was independently associated with a worse outcome. AJCD
Copyright © 2021.

Entities:  

Keywords:  Chronic kidney disease; congenital heart disease; cyanosis; glomerular filtration rate; survival

Year:  2021        PMID: 33815919      PMCID: PMC8012297     

Source DB:  PubMed          Journal:  Am J Cardiovasc Dis        ISSN: 2160-200X


  17 in total

1.  Cardiovascular risk factors and arterial thrombotic events in congenital heart disease patients.

Authors:  Efrén Martínez-Quintana; Juan Lizandro Rodríguez-Hernández; Fayna Rodríguez-González; Marta Riaño-Ruiz; Carla Fraguela-Medina; Angela Girolimetti; Sara Jiménez-Rodríguez
Journal:  Int J Clin Pract       Date:  2019-06-28       Impact factor: 2.503

2.  Consensus document. Recommendations on assessing proteinuria during the diagnosis and follow-up of chronic kidney disease.

Authors:  R Montañés Bermúdez; S Gràcia García; D Pérez Surribas; A Martínez Castelao; J Bover Sanjuán
Journal:  Nefrologia       Date:  2011       Impact factor: 2.033

3.  Relation between kidney function, proteinuria, and adverse outcomes.

Authors:  Brenda R Hemmelgarn; Braden J Manns; Anita Lloyd; Matthew T James; Scott Klarenbach; Robert R Quinn; Natasha Wiebe; Marcello Tonelli
Journal:  JAMA       Date:  2010-02-03       Impact factor: 56.272

4.  Chronic kidney disease and measurement of albuminuria or proteinuria: a position statement.

Authors:  David W Johnson; Graham R D Jones; Timothy H Mathew; Marie J Ludlow; Stephen J Chadban; Tim Usherwood; Kevan Polkinghorne; Stephen Colagiuri; George Jerums; Richard Macisaac; Helen Martin
Journal:  Med J Aust       Date:  2012-08-20       Impact factor: 7.738

Review 5.  Clinical update on adults with congenital heart disease.

Authors:  Judith Therrien; Gary Webb
Journal:  Lancet       Date:  2003-10-18       Impact factor: 79.321

6.  Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease.

Authors:  Konstantinos Dimopoulos; Gerhard-Paul Diller; Evdokia Koltsida; Antonia Pijuan-Domenech; Sofia A Papadopoulou; Sonya V Babu-Narayan; Tushar V Salukhe; Massimo F Piepoli; Philip A Poole-Wilson; Nicky Best; Darrel P Francis; Michael A Gatzoulis
Journal:  Circulation       Date:  2008-04-28       Impact factor: 29.690

7.  Proteinuria and clinical outcome in CHD patients.

Authors:  Efrén Martínez-Quintana; Fayna Rodríguez-González
Journal:  Cardiol Young       Date:  2014-08-28       Impact factor: 1.093

Review 8.  Acute kidney injury associated with cardiac surgery.

Authors:  Mitchell H Rosner; Mark D Okusa
Journal:  Clin J Am Soc Nephrol       Date:  2005-10-19       Impact factor: 8.237

Review 9.  Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.

Authors:  Ron T Gansevoort; Ricardo Correa-Rotter; Brenda R Hemmelgarn; Tazeen H Jafar; Hiddo J Lambers Heerspink; Johannes F Mann; Kunihiro Matsushita; Chi Pang Wen
Journal:  Lancet       Date:  2013-05-31       Impact factor: 79.321

Review 10.  Chronic kidney disease in congenital heart disease patients: a narrative review of evidence.

Authors:  Catherine Morgan; Mohammed Al-Aklabi; Gonzalo Garcia Guerra
Journal:  Can J Kidney Health Dis       Date:  2015-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.